Ritlecitinib tosylate
| CAS No. | 2192215-81-7 | Cat. No. | BCP45991 |
| Name | Ritlecitinib tosylate | ||
| Synonyms | PF-06651600; PF 06651600; PF06651600; PF-6651600; PF 6651600; PF6651600; | ||
| Formula | C22H27N5O4S | M. Wt | 457.55 |
| Description | Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF-06651600 is a potent and low clearance compound with demonstrated in vivo efficacy. The favorable efficacy and safety profile of this JAK3-specific inhibitor PF-06651600 led to its evaluation in several human clinical studies. JAK3 was among the first of the JAKs targeted for therapeutic intervention due to the strong validation provided by human SCID patients displaying JAK3 deficiencies. | ||
| Related Products | 1792180-81-4（Ritlecitinib） | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase Jak/Stat Pathway Wnt/Stem Cell Epigenetics | ||
| Targets | JAK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.